Please Login to read the full article.
Veeda to open Phase I unit in Malaysia
19 May 2011
|
Gemma Sharman
Scrip Clinical Research
Not
a subscriber ? Request a FREE Trial
Subscribe to GCPj
Other News
First UK medtech campus: innovation-focused and a hot-house for industry
Four brands but no MabThera in Indian rituximab market flux
Pfenex-Agila plot cost-effective joint effort for biosimilars
Strides wants Malaysian unit to transform biologic economics
FEATURES & ANALYSIS
Scrip Clinical Research Features & Analysis
Evaluation of cardiovascular risk in clinical trials
Get on the technology train; how to train global nurses
EndPoint - Dr Frederick Young, INC Research
New approaches bring hope for peripheral artery disease
Other Features & Analysis
Eucomed: proposed overhaul of EU reg system mostly positive with one caveat
How the evolving Brazilian and Russian healthcare landscape will impact medtech firms
Real-world and late-phase studies in "pharmerging" markets: challenges and best practices in implementation
Accessing the Indian and Chinese healthcare markets: is the opportunity worth the investment?
EVENTS
Expecting data for this section.
